Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,586.32
(
1.23%
)
US TECH 100
23,508.80
(
0.97%
)
Dow Jones
46,255.17
(
1.49%
)
Brent Oil
97.80
(
-9.56%
)
Bitcoin
70,716.66
(
4.24%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 160680

Friday, 05/03/2013 8:31:31 AM

Friday, May 03, 2013 8:31:31 AM

Post# of 257269

They are now testing Sofo/PegRiba for 24-weeks, a study that conveniently won't mature until after oral review.




Can anyone point to data suggesting 12-weeks of Sofo/PegRiba isn't long enough to produce exceptional SVR rates in GT3?






Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today